Search for: "TEVA PHARMACEUTICALS, INC."
Results 1 - 20
of 838
Sort by Relevance
|
Sort by Date
6 May 2024, 8:26 am
The Federal Trade Commission (FTC) announced late last month that it had “expanded its campaign against pharmaceutical manufacturers’ improper or inaccurate listing of patents in the Food and Drug Administration’s (FDA) Orange Book, disputing junk patent listings for diabetes, weight loss, asthma, and COPD drugs, including Novo Nordisk Inc. [read post]
1 May 2024, 1:18 pm
Teva Pharmaceuticals, an AKS-based FCA case involving speaker programs sponsored by drug manufacturers, the U.S. [read post]
28 Apr 2024, 8:18 pm
Teva Pharmaceuticals USA, Inc. [read post]
24 Apr 2024, 9:27 pm
Teva Pharmaceuticals USA, Inc. [read post]
16 Apr 2024, 8:42 am
Teva Pharms. [read post]
14 Apr 2024, 9:19 pm
Noonan -- In its recent decision in Janssen Pharmaceuticals, Inc. v. [read post]
8 Apr 2024, 9:47 am
Teva Pharms. [read post]
3 Apr 2024, 1:07 pm
The Federal Trade Commission (“FTC”) has filed an amicus brief in Teva Branded Pharmaceuticals Products R&D, Inc. v. [read post]
1 Apr 2024, 10:58 am
Janssen Pharms., Inc. v. [read post]
1 Apr 2024, 10:15 am
Court of Appeals for the Federal Circuit (CAFC) ruled in a precedential decision authored by Judge Prost on Monday that certain claims of Janssen Pharmaceuticals Inc. [read post]
1 Apr 2024, 10:15 am
Court of Appeals for the Federal Circuit (CAFC) ruled in a precedential decision authored by Judge Prost on Monday that certain claims of Janssen Pharmaceuticals Inc. [read post]
27 Mar 2024, 10:56 am
The 2019 decision Amgen Inc. v. [read post]
26 Mar 2024, 7:01 pm
Late last week, the FTC submitted an Amicus Brief in recent Hatch-Waxman patent litigation in the District Court of New Jersey between Reference Listed Drug holder Teva Branded Pharmaceutical Products R&D Inc. and ANDA applicant Amneal Pharmaceuticals explaining that patents that claim the device constituent of a combination product but do not expressly claim the relevant drug substance should not be listed in the Orange Book. [read post]
Celanese v. ITC: Can a Secret Manufacturing Process Be Patented After Sale of the Resulting Product?
4 Mar 2024, 9:45 am
Teva Pharmaceuticals USA, Inc. held that in the AIA, Congress did not change the meaning of “on sale” from the pre-AIA statute. [read post]
19 Feb 2024, 12:55 pm
Altoona Publix Theatres, Inc. v. [read post]
23 Jan 2024, 9:01 pm
In 2022, Teva Pharmaceutical Industries Ltd. also settled shareholder allegations related to the price-fixing scheme for $420 million. 7.) [read post]
23 Jan 2024, 3:43 am
Teva Pharmaceuticals USA, Inc., 23-768 (Supreme Court). [read post]
18 Jan 2024, 9:16 am
Teva Pharmaceuticals USA, Inc., 7 F.4th 1320, 1333 (Fed. [read post]
18 Dec 2023, 10:00 pm
Teva Pharm. [read post]
18 Dec 2023, 9:07 pm
Teva Pharmaceuticals USA (Fed. [read post]
